HomeACRS • NASDAQ
add
Aclaris Therapeutics Inc
Previous close
$1.15
Day range
$1.12 - $1.19
Year range
$0.95 - $5.17
Market cap
127.34M USD
Avg Volume
1.11M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
14 hours ago
S&P 500 tallies its first ‘death cross’ in 3 years. Here’s what happens next.
0.79%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 9.21M | -47.58% |
Operating expense | -17.41M | 68.48% |
Net income | -96.55M | -6,375.65% |
Net profit margin | -1.05K | -12,246.53% |
Earnings per share | -1.01 | -4,950.00% |
EBITDA | -14.03M | 31.48% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 113.59M | -4.63% |
Total assets | 220.33M | 11.61% |
Total liabilities | 64.77M | 61.02% |
Total equity | 155.55M | — |
Shares outstanding | 107.92M | — |
Price to book | 0.80 | — |
Return on assets | -17.47% | — |
Return on capital | -24.21% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -96.55M | -6,375.65% |
Cash from operations | -8.94M | -32.20% |
Cash from investing | -88.72M | -1,275.14% |
Cash from financing | 74.58M | 152,104.08% |
Net change in cash | -23.08M | -2,854.30% |
Free cash flow | -37.05M | -1,989.74% |
About
Founded
2012
Website
Employees
63
